Immunization using GroEL decreases Clostridium difficile intestinal colonization

PLoS One. 2013 Nov 26;8(11):e81112. doi: 10.1371/journal.pone.0081112. eCollection 2013.

Abstract

Clostridium difficile is a pathogen which is responsible for diarrhea and colitis, particularly after treatment with antibiotics. Clinical signs are mainly due to two toxins, TcdA and TcdB. However, the first step of pathogenesis is the colonization process. We evaluated C. difficile surface proteins as vaccine antigens in the hamster model to prevent intestinal colonization. This vaccination induced a partial protection of hamsters against death after a C. difficile challenge. A proteomic analysis of animal sera allowed us to identify proteins which could be responsible for the protection observed. Among these proteins, we identified the GroEL heat shock protein. To confirm the role of the specific GroEL antibodies in the delayed C. difficile colonization of hamsters, we performed an immunization assay in a mouse model. After intranasal immunization with the recombinant protein GroEL, we observed a lower C. difficile intestinal colonization in the immunized group as compared to the control group.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Bacterial / blood
  • Antibodies, Bacterial / immunology
  • Antibody Specificity / immunology
  • Bacterial Proteins / immunology*
  • Bacterial Proteins / metabolism
  • Bacterial Vaccines / immunology
  • Cell Wall / immunology
  • Cell Wall / metabolism
  • Chaperonin 60 / immunology*
  • Chaperonin 60 / metabolism
  • Clostridioides difficile / immunology*
  • Clostridioides difficile / metabolism
  • Cricetinae
  • Disease Models, Animal
  • Enterocolitis, Pseudomembranous / immunology
  • Enterocolitis, Pseudomembranous / microbiology
  • Enterocolitis, Pseudomembranous / mortality
  • Female
  • Immunization
  • Intestines / immunology*
  • Intestines / microbiology*
  • Mice
  • Proteomics / methods
  • Recombinant Proteins / immunology

Substances

  • Antibodies, Bacterial
  • Bacterial Proteins
  • Bacterial Vaccines
  • Chaperonin 60
  • Recombinant Proteins

Grants and funding

Fundings from the French ministery of research supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.